BiopharmaTrend.com

Atomwise

Atomwise

Private company
ATOMWISE

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.


Founded
2012
Status
Private company
Geography
United States of America based
Funding
$174.345 M
Patents
3
Research papers
6

Products

AtomNet

Drug design with convolutional neural networks

Using artificial intelligence for structure-based drug discovery (SBDD). Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page